Patriot Financial Group Insurance Agency’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-66
Closed -$7K 2318
2021
Q4
$7K Hold
66
﹤0.01% 1635
2021
Q3
$7K Sell
66
-26
-28% -$2.7K ﹤0.01% 1619
2021
Q2
$9K Hold
92
﹤0.01% 1494
2021
Q1
$8K Sell
92
-134
-59% -$11.3K ﹤0.01% 1449
2020
Q4
$17K Buy
+226
New +$16.8K ﹤0.01% 1046

Other funds holding HZNP

Patriot Financial Group Insurance Agency's HZNP Position: Q1 2022 in Review

Patriot Financial Group Insurance Agency sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2022, closing a stake of 66 shares — an estimated $7K sold.

Patriot Financial Group Insurance Agency first reported a position in HZNP in Q4 2020 and held it in 5 quarters. The position peaked at $17K in Q4 2020. 620 funds tracked by Wall St. Rank hold HZNP as of Q1 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 66 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2022, an estimated $7K.
  • Patriot Financial Group Insurance Agency first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 5 quarters.
  • Patriot Financial Group Insurance Agency's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $17K in Q4 2020.
  • 620 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2022, filed 11 May 2022.